Synaptogenix, Inc. (SNPX)
NASDAQ: SNPX · Real-Time Price · USD
7.85
+1.80 (29.75%)
At close: Jun 30, 2025, 4:00 PM
7.92
+0.07 (0.89%)
After-hours: Jun 30, 2025, 7:59 PM EDT
Synaptogenix Market Cap
Synaptogenix has a market cap or net worth of $10.91 million as of June 30, 2025. Its market cap has increased by 112.15% in one year.
Market Cap
10.91M
Enterprise Value
-3.92M
1-Year Change
112.15%
Ranking
Category
Stock Price
$7.85
Market Cap Chart
Since December 15, 2020, Synaptogenix's market cap has increased from $5.28M to $10.91M, an increase of 106.56%. That is a compound annual growth rate of 17.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 27, 2025 | 8.40M | 78.60% |
| Dec 31, 2024 | 4.70M | -15.16% |
| Dec 29, 2023 | 5.54M | -34.23% |
| Dec 30, 2022 | 8.43M | -85.16% |
| Dec 31, 2021 | 56.80M | 652.77% |
| Dec 31, 2020 | 7.55M | 42.86% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 699.81B |
| Johnson & Johnson | 367.53B |
| AbbVie | 327.88B |
| Novo Nordisk | 307.21B |
| UnitedHealth Group | 283.00B |
| Novartis AG | 236.92B |
| Abbott Laboratories | 236.64B |
| AstraZeneca | 215.00B |